Evidence map›Paper›PMID 37942268›Full record

ReviewACS catalysis2023

Accelerating Biocatalysis Discovery with Machine Learning: A Paradigm Shift in Enzyme Engineering, Discovery, and Design.

Braun Markus, Gruber Christian C, Krassnigg Andreas, Kummer Arkadij, Lutz Stefan, Oberdorfer Gustav, Siirola Elina, Snajdrova Radka

Open access · hybridAbstract readReview
In one paragraph

Review in ACS catalysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 80 citations in OpenAlex.

  1. Next-Generation Manufacturing: The Evolving Role of Biocatalysis in AstraZeneca.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. High-level production of vitamin K2 inSynthetic and systems biotechnology · 2026
    Article
  9. Article
  10. Advances in Machine Learning Models for Predicting Enzyme Kinetic Parameters.Journal of chemical information and modeling · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Deep-Learning Driven Identification of Novel Antimicrobial Peptides.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Braun MarkusDepartment of Biochemistry, Graz University of Technology, Petersgasse 12/2, 8010 Graz, Austria.
Gruber Christian CEnzyme and Drug Discovery, Innophore. 1700 Montgomery Street, San Francisco, California 94111, United States.
Krassnigg AndreasEnzyme and Drug Discovery, Innophore. 1700 Montgomery Street, San Francisco, California 94111, United States.
Kummer ArkadijModerna, Inc., 200 Technology Square, Cambridge, Massachusetts 02139, United States.
Lutz StefanCodexis Inc., 200 Penobscot Drive, Redwood City, California 94063, United States.
Oberdorfer GustavDepartment of Biochemistry, Graz University of Technology, Petersgasse 12/2, 8010 Graz, Austria.
Siirola ElinaNovartis Institute for Biomedical Research, Global Discovery Chemistry, Basel CH-4108, Switzerland.
Snajdrova RadkaNovartis Institute for Biomedical Research, Global Discovery Chemistry, Basel CH-4108, Switzerland.ORCID https://orcid.org/0000-0002-4809-1066
Graz University of Technology · ATNovartis (Switzerland) · CHCodexis (United States) · USModerna Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging computational tools promise to revolutionize protein engineering for biocatalytic applications and accelerate the development timelines previously needed to optimize an enzyme to its more efficient variant. For over a decade, the benefits of predictive algorithms have helped scientists and engineers navigate the complexity of functional protein sequence space. More recently, spurred by dramatic advances in underlying computational tools, the promise of faster, cheaper, and more accurate enzyme identification, characterization, and engineering has catapulted terms such as artificial intelligence and machine learning to the must-have vocabulary in the field. This Perspective aims to showcase the current status of applications in pharmaceutical industry and also to discuss and celebrate the innovative approaches in protein science by highlighting their potential in selected recent developments and offering thoughts on future opportunities for biocatalysis. It also critically assesses the technology's limitations, unanswered questions, and unmet challenges.

Identifiers

PMID37942268
PMCPMC10629211
OpenAlexW4388200983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.